DZ3164A1 - Nouvel agent pharmaceutique. - Google Patents

Nouvel agent pharmaceutique.

Info

Publication number: DZ3164A1
Authority: DZ; Algeria
Prior art keywords: pharmaceutical agent; new pharmaceutical; new; agent; pharmaceutical
Prior art date: 1999-04-23

Application number

DZ003164A

Other languages

English (en)

Inventor

Paul David James Blackler

Robert Gordon Giles

Stephen Moore

Michael John Sasse

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-23

Filing date

2000-04-19

Publication date

2000-11-02

1999-04-23 Priority claimed from GBGB9909471.6A external-priority patent/GB9909471D0/en

1999-05-25 Priority claimed from GBGB9912195.6A external-priority patent/GB9912195D0/en

2000-04-19 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-11-02 Application granted granted Critical

2000-11-02 Publication of DZ3164A1 publication Critical patent/DZ3164A1/fr

Links

239000008177 pharmaceutical agent Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Hematology (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Steroid Compounds (AREA)

DZ003164A 1999-04-23 2000-04-19 Nouvel agent pharmaceutique. DZ3164A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9909471.6A GB9909471D0 (en)	1999-04-23	1999-04-23	Novel compounds
GBGB9912195.6A GB9912195D0 (en)	1999-05-25	1999-05-25	Novel pharmaceutical
PCT/GB2000/001522 WO2000064893A2 (fr)	1999-04-23	2000-04-19	Nouvel agent pharmaceutique

Publications (1)

Publication Number	Publication Date
DZ3164A1 true DZ3164A1 (fr)	2000-11-02

Family

ID=26315459

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003164A DZ3164A1 (fr)	1999-04-23	2000-04-19	Nouvel agent pharmaceutique.

Country Status (36)

Country	Link
EP (2)	EP1175418A2 (fr)
JP (1)	JP2002543076A (fr)
KR (1)	KR100744361B1 (fr)
CN (1)	CN1152878C (fr)
AP (1)	AP1607A (fr)
AR (2)	AR023750A1 (fr)
AU (2)	AU4307200A (fr)
BG (1)	BG65517B1 (fr)
BR (1)	BR0009935A (fr)
CA (1)	CA2370262A1 (fr)
CO (1)	CO5170419A1 (fr)
CZ (1)	CZ20013801A3 (fr)
DZ (1)	DZ3164A1 (fr)
EA (1)	EA003031B1 (fr)
EG (1)	EG23937A (fr)
GC (1)	GC0000250A (fr)
HK (1)	HK1045152A1 (fr)
HR (1)	HRP20010774A2 (fr)
HU (1)	HUP0200937A3 (fr)
IL (1)	IL146115A0 (fr)
MA (1)	MA26786A1 (fr)
MX (1)	MXPA01010822A (fr)
MY (1)	MY138673A (fr)
NO (1)	NO320587B1 (fr)
NZ (1)	NZ515167A (fr)
OA (1)	OA11873A (fr)
PE (1)	PE20010045A1 (fr)
PL (1)	PL351685A1 (fr)
SK (1)	SK14932001A3 (fr)
TR (1)	TR200103060T2 (fr)
TW (1)	TWI288749B (fr)
UA (1)	UA67845C2 (fr)
UY (1)	UY26119A1 (fr)
WO (1)	WO2000064893A2 (fr)
YU (1)	YU75401A (fr)
ZA (1)	ZA200108718B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9726568D0 (en)	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en)	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
JP2002541785A (ja) *	1999-04-13	2002-12-10	アメリカ合衆国	クローン化ヌクレオチド配列からの弱毒化キメラ呼吸系発疹ウイルスワクチンの製造
HRP20010773B1 (en)	1999-04-23	2005-06-30	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
AR023561A1 (es)	1999-04-23	2002-09-04	Smithkline Beecham Corp	Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
GB0006133D0 (en)	2000-03-14	2000-05-03	Smithkline Beecham Plc	Novel pharmaceutical
US7241895B2 (en) *	2000-09-26	2007-07-10	Dr. Reddy's Laboratories Limited	Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2004062667A1 (fr) *	2003-01-08	2004-07-29	Dr. Reddy's Laboratories Limited	Forme amorphe du maleate de rosiglitazone et procede de preparation
GB0307259D0 (en) *	2003-03-28	2003-05-07	Glaxo Group Ltd	Process
EP1468997A3 (fr) *	2003-04-18	2004-11-03	CHEMI S.p.A.	Formes polymorphes de maléate de rosiglitatone
GB2405403A (en) *	2003-08-29	2005-03-02	Cipla Ltd	Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) *	2004-07-28	2004-10-28	Chemi Spa	Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) *	2005-05-24	2007-09-26	Zentiva, A. S.	Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
TW201336497A (zh) *	2007-02-08	2013-09-16	Daiichi Sankyo Co Ltd	噻唑啶二酮化合物之結晶型及其製法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
GB9726568D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
GB9726566D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
GB9726563D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical

2000
- 2000-04-19 CZ CZ20013801A patent/CZ20013801A3/cs unknown
- 2000-04-19 PL PL00351685A patent/PL351685A1/xx not_active Application Discontinuation
- 2000-04-19 EA EA200101122A patent/EA003031B1/ru not_active IP Right Cessation
- 2000-04-19 WO PCT/GB2000/001522 patent/WO2000064893A2/fr not_active Ceased
- 2000-04-19 AU AU43072/00A patent/AU4307200A/en not_active Abandoned
- 2000-04-19 PE PE2000000363A patent/PE20010045A1/es not_active Application Discontinuation
- 2000-04-19 AR ARP000101866A patent/AR023750A1/es unknown
- 2000-04-19 HR HR20010774A patent/HRP20010774A2/hr not_active Application Discontinuation
- 2000-04-19 YU YU75401A patent/YU75401A/sh unknown
- 2000-04-19 DZ DZ003164A patent/DZ3164A1/fr active
- 2000-04-19 OA OA1200100277A patent/OA11873A/en unknown
- 2000-04-19 CA CA002370262A patent/CA2370262A1/fr not_active Abandoned
- 2000-04-19 HU HU0200937A patent/HUP0200937A3/hu unknown
- 2000-04-19 JP JP2000614245A patent/JP2002543076A/ja active Pending
- 2000-04-19 EP EP00922793A patent/EP1175418A2/fr not_active Withdrawn
- 2000-04-19 NZ NZ515167A patent/NZ515167A/xx unknown
- 2000-04-19 AR ARP000101861A patent/AR023560A1/es unknown
- 2000-04-19 MX MXPA01010822A patent/MXPA01010822A/es active IP Right Grant
- 2000-04-19 TR TR2001/03060T patent/TR200103060T2/xx unknown
- 2000-04-19 CN CNB008090548A patent/CN1152878C/zh not_active Expired - Fee Related
- 2000-04-19 CO CO00028927A patent/CO5170419A1/es not_active Application Discontinuation
- 2000-04-19 EP EP02080319A patent/EP1277753A1/fr not_active Withdrawn
- 2000-04-19 BR BR0009935-0A patent/BR0009935A/pt not_active Application Discontinuation
- 2000-04-19 UA UA2001117940A patent/UA67845C2/uk unknown
- 2000-04-19 SK SK1493-2001A patent/SK14932001A3/sk unknown
- 2000-04-19 HK HK02104877.8A patent/HK1045152A1/zh unknown
- 2000-04-19 KR KR1020017013592A patent/KR100744361B1/ko not_active Expired - Fee Related
- 2000-04-19 IL IL14611500A patent/IL146115A0/xx unknown
- 2000-04-19 AP APAP/P/2001/002329A patent/AP1607A/en active
- 2000-04-21 MY MYPI20001706A patent/MY138673A/en unknown
- 2000-04-22 EG EG20000511A patent/EG23937A/xx active
- 2000-04-23 GC GCP2000625 patent/GC0000250A/en active
- 2000-04-24 TW TW089107636A patent/TWI288749B/zh not_active IP Right Cessation
- 2000-04-24 UY UY26119A patent/UY26119A1/es not_active Application Discontinuation
2001
- 2001-10-22 MA MA26379A patent/MA26786A1/fr unknown
- 2001-10-22 NO NO20015148A patent/NO320587B1/no unknown
- 2001-10-23 ZA ZA200108718A patent/ZA200108718B/xx unknown
- 2001-11-20 BG BG106122A patent/BG65517B1/bg unknown
2002
- 2002-03-20 AU AU27551/02A patent/AU771342B2/en not_active Ceased

Also Published As

Publication number	Publication date
EP1277753A1 (fr)	2003-01-22
YU75401A (sh)	2004-09-03
OA11873A (en)	2006-03-27
AR023750A1 (es)	2002-09-04
NO20015148L (no)	2001-12-17
NZ515167A (en)	2004-02-27
PL351685A1 (en)	2003-06-02
BG106122A (en)	2002-05-31
CA2370262A1 (fr)	2000-11-02
CN1355800A (zh)	2002-06-26
KR100744361B1 (ko)	2007-07-30
PE20010045A1 (es)	2001-03-10
GC0000250A (en)	2006-11-01
AU2755102A (en)	2002-05-16
AR023560A1 (es)	2002-09-04
EG23937A (en)	2008-01-14
KR20010110804A (ko)	2001-12-13
IL146115A0 (en)	2002-07-25
TWI288749B (en)	2007-10-21
HUP0200937A2 (en)	2002-08-28
MA26786A1 (fr)	2004-12-20
AU4307200A (en)	2000-11-10
CO5170419A1 (es)	2002-06-27
HRP20010774A2 (en)	2002-10-31
CN1152878C (zh)	2004-06-09
MY138673A (en)	2009-07-31
MXPA01010822A (es)	2002-06-04
SK14932001A3 (sk)	2002-02-05
AP1607A (en)	2006-05-03
AU771342B2 (en)	2004-03-18
HUP0200937A3 (en)	2004-03-29
NO20015148D0 (no)	2001-10-22
EP1175418A2 (fr)	2002-01-30
NO320587B1 (no)	2005-12-27
ZA200108718B (en)	2002-12-03
CZ20013801A3 (cs)	2002-07-17
HK1045152A1 (zh)	2002-11-15
JP2002543076A (ja)	2002-12-17
UY26119A1 (es)	2000-12-29
BR0009935A (pt)	2002-04-16
EA200101122A1 (ru)	2002-04-25
WO2000064893A2 (fr)	2000-11-02
WO2000064893A3 (fr)	2001-01-25
AP2001002329A0 (en)	2001-12-31
BG65517B1 (bg)	2008-10-31
UA67845C2 (uk)	2004-07-15
TR200103060T2 (tr)	2002-05-21
EA003031B1 (ru)	2002-12-26

Publication	Publication Date	Title
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
MA26937A1 (fr)	2004-12-20	Nouvelle composition pharmaceutique.
FI991485L (fi)	2000-12-31	Uusi farmaseuttinen koostumus
DZ2516A1 (fr)	2004-11-08	Composition pharmaceutique en aérosol.
NL1015859A1 (nl)	2001-07-27	Farmaceutische preparaten.
NO20015175D0 (no)	2001-10-23	Farmasöytisk sammensetning
ITTO20010005A1 (it)	2001-07-11	Formulazione farmaceutica.
BR0014930B1 (pt)	2009-01-13	cÂnula.
DE60016271D1 (de)	2004-12-30	Medikamentenzuführvorrichtung
DE122010000009I2 (de)	2012-08-09	Beta2-adrenoceptor agonisten.
NO20020304D0 (no)	2002-01-21	Konserverte farmasöytiske preparater
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
MXPA03001425A (es)	2003-06-06	Compuestos farmaceuticos.
DZ3155A1 (fr)	2000-11-02	Nouvelle composition pharmaceutique.
PT1210085E (pt)	2006-05-31	Solucoes farmaceuticas de levosimendano
DK1275397T3 (da)	2014-09-22	Lægemiddel til lokal anvendelse
NO20022606D0 (no)	2002-05-31	Farmasöytiske kombinasjoner
NO20014926L (no)	2001-12-13	Farmasöytiske forbindelser
DK1227817T3 (da)	2004-11-15	Ciclesonid-holdigt vandigt farmaceutisk præparat
ITTO20000385A0 (it)	2000-04-21	Composizione pesticida.
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
DZ3163A1 (fr)	2000-10-26	Nouvelle substance pharmaceutique.
DZ3162A1 (fr)	2000-10-26	Nouveau composé pharmaceutique.
MA26801A1 (fr)	2004-12-20	Complexe pharmaceutique